Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 83Myeloid 40Lymphoid 17Classical hematology 5Gastrointestinal 3Gynecologic 2Genitourinary 2Breast 2Thoracic 1Head & Neck 1Endocrine 1

Conditions

Pancreatic Adenocarcinoma Metastatic 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Decitabine × Gastrointestinal × Clear all
NCT07007767 2025-06-06

Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Not yet recruiting
32 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT05360264 2025-03-24

ORIENTATE

Regina Elena Cancer Institute

Phase 2 Terminated
7 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT05265962 2022-03-04

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

The First Affiliated Hospital of Zhengzhou University

Phase 2 Unknown
85 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡